World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
27183
World Ranking
10196
National Ranking
562

Overview

Manfred Dietel is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields including Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine and Imaging.

Their work covers several key topics such as Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Colorectal and Anal Carcinomas, Radiomics and Machine Learning in Medical Imaging, and PARP inhibition in cancer therapy.

Frequent coauthors collaborating with Manfred Dietel include Sabine Merkelbach-Bruse, Wolfgang Dietmaier, Korinna Jöhrens, Albrecht Stenzinger, and Reinhard Büttner.

The scientist has published extensively in various venues. Notable publication venues where multiple works have appeared are:

  • Die Pathologie
  • Der Pathologe
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Journal for ImmunoTherapy of Cancer
  • Journal of Thoracic Oncology

Some of the recent papers authored or coauthored by Manfred Dietel include:

  • Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project, 2020, Journal for ImmunoTherapy of Cancer
  • Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study, 2020, Journal of Thoracic Oncology
  • <scp>NTRK</scp> testing: First results of the <scp>QuiP-EQA</scp> scheme and a comprehensive map of <scp><i>NTRK</i></scp> fusion variants and their diagnostic coverage by targeted <scp>RNA</scp>-based <scp>NGS</scp> assays, 2020, Genes Chromosomes and Cancer
  • Testing for deficient mismatch repair and microsatellite instability, 2023, Die Pathologie
  • MSI testing, 2021, Der Pathologe

Best Publications

  • Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

    Carsten Denkert;Gunter von Minckwitz;Jan C. Brase;Bruno V. Sinn

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

    W Weichert;A Röske;V Gekeler;T Beckers

  • Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

    Douglas D. Ross;Weidong Yang;Lynne V. Abruzzo;William S. Dalton

  • Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

    Carsten Denkert;Jan Budczies;Tobias Kind;Wilko Weichert

  • Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

    Wilko Weichert;Annika Röske;Volker Gekeler;Thomas Beckers

  • Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.

    Olaf Kaufmann;Ellen Fietze;Jörg Mengs;Manfred Dietel

  • Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

    Reinhard Büttner;John R Gosney;Birgit Guldhammer Skov;Julien Adam

  • Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

    Carsten Denkert;Jan Budczies;Wilko Weichert;Gert Wohlgemuth

  • Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.

    O Kaufmann;M Dietel

  • Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas

    Andreas H Scheel;Manfred Dietel;Lukas C Heukamp;Korinna Jöhrens

  • Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

    Robert Pirker;Felix J F Herth;Keith M. Kerr;Martin Filipits

  • Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.

    Kaufmann O;Dietel M

  • ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.

    W Weichert;T Knösel;J Bellach;M Dietel

  • ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.

    Caterina Marchiò;Maurizio Scaltriti;Marc Ladanyi;Anthony J Iafrate

  • Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.

    Aurelia Noske;Wilko Weichert;Silvia Niesporek;Annika Röske

  • Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach

    Stephan Wienert;Daniel Heim;Kai Saeger;Albrecht Stenzinger

  • EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

    Erik Thunnissen;Lukas Bubendorf;Manfred Dietel;Göran Elmberger

  • The landscape of metastatic progression patterns across major human cancers.

    Jan Budczies;Moritz von Winterfeld;Frederick Klauschen;Michael Bockmayr

  • Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer - A Substudy of the Neoadjuvant GeparQuinto Trial

    Yasmin Issa-Nummer;Silvia Darb-Esfahani;Sibylle Loibl;Georg Kunz

Frequent Co-Authors

Carsten Denkert
Carsten Denkert Philipp University of Marburg
Wilko Weichert
Wilko Weichert Technical University of Munich
Glen Kristiansen
Glen Kristiansen University Hospital Bonn
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Albrecht Stenzinger
Albrecht Stenzinger Heidelberg University
Jalid Sehouli
Jalid Sehouli Charité - University Medicine Berlin
Carsten Stephan
Carsten Stephan Charité - University Medicine Berlin
Michael Hummel
Michael Hummel Charité - University Medicine Berlin
Reinhard Büttner
Reinhard Büttner University Hospital Cologne
Christine Sers
Christine Sers Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the medical field but considering alternative paths to becoming a physician? There are a variety of rewarding roles in healthcare that offer flexible online degree options. For those looking to enter nursing, researching the easiest rn program can help you find accessible routes into the profession, even if your academic background is not traditional.

If direct patient care isn’t your ideal fit, consider the growing field of healthcare administration. Earning a healthcare administration degree online accredited allows you to develop in-demand leadership and organizational skills while studying at your own pace.

Medical billing and coding is another crucial area, with top programs now offered remotely. Explore the best medical billing and coding schools online to find accredited options that may provide financial aid opportunities.

Many nursing schools have streamlined their admissions, and you may be wondering, do i need to take the teas test for lpn? Some programs no longer require standardized entrance exams, making entry even more accessible.

Best Scientists Citing Manfred Dietel

Trending Scientists